Molecular biology and oral contraception

Area of Science:

• Endocrinology
• Pharmacology
• Reproductive Health

Background:

• Advances in understanding sex hormone receptors and steroid metabolism inform oral contraceptive selection.
• Dose-dependent metabolic effects of synthetic estrogens are well-documented.
• Norgestrel antagonizes estrogenic actions, unlike other progestogens.

Purpose of the Study:

• To guide rational selection of oral contraceptive steroids based on current scientific knowledge.
• To evaluate the relationship between oral contraceptive use and lysosomal enzyme activation.
• To identify the most suitable oral contraceptive formulation.

Main Methods:

• Review of recent developments in sex hormone receptor and steroid metabolism knowledge.
• Analysis of dose-related metabolic effects of synthetic estrogens.
• Assessment of lysosomal enzyme activation in oral contraceptive users.
• Clinical evaluation of a low-dose combination product.

Main Results:

• Lysosomal enzyme activation in users correlates with total steroid dose per cycle, not specific products.
• Norgestrel demonstrates unique antagonism of estrogenic effects compared to other progestogens.
• Lowest dose combinations of ethinylestradiol and d-norgestrel are suggested as optimal.

Conclusions:

• The lowest dose combination of ethinylestradiol and d-norgestrel is the preferred oral contraceptive choice.
• Understanding steroid metabolism and receptor interactions is crucial for effective oral contraception.
• Clinical outcomes support the use of low-dose combination oral contraceptives.